General Information of the Compound
Compound ID |
CP0025667
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-[4-(4-Methyl-benzyl)-piperazin-1-yl]-1-(2-methyl-2,3-dihydro-indol-1-yl)-ethanone
Show/Hide
|
||||||||||||||||||
Synonyms |
3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine
8-Chloro-11-(4-methyl)-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo (b,e)(1,4)diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine
8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]-diazepine
8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
Asaleptin
C 6305
CLOZARIL
Clopine (TN)
Clorazil
Clozapin
Clozapina
Clozapina [INN-Spanish]
Clozapine
Clozapine (JAN/USP/INN)
Clozapine [USAN:INN:BAN]
Clozapine(tautomer)
Clozapinum
Clozapinum [INN-Latin]
Clozaril (TN)
Denzapine (TN)
Fazaclo
Fazaclo (TN)
Fazaclo ODT
Froidir (TN)
HF-1854
HF1854
Iprox
KS-1166
Klozapol (TN)
LEX-123
LX 100-129
Leponex
Leponex (TN)
Lepotex
W-801
Zaponex (TN)
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C18H19ClN4
|
||||||||||||||||||
Molecular Weight |
326.831
|
||||||||||||||||||
Canonical SMILES |
CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3
Show/Hide
|
||||||||||||||||||
InChIKey |
QZUDBNBUXVUHMW-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
5786-21-0
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Cell-based Assay
Protein ID: PT01019, 5-hydroxytryptamine receptor 2B
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Cell-based Assay
Protein ID: PT00941, 5-hydroxytryptamine receptor 7
Cell-based Assay
Protein ID: PT01195, D(1A) dopamine receptor
Protein ID: PT01358, D(1A) dopamine receptor
Protein ID: PT01169, D(1B) dopamine receptor
Protein ID: PT01005, D(2) dopamine receptor
Cell-based Assay
Biochemical Assays
Protein ID: PT00957, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor
Cell-based Assay
Protein ID: PT01366, D(3) dopamine receptor
Cell-based Assay
Protein ID: PT01161, D(4) dopamine receptor
Cell-based Assay
Biochemical Assays
Protein ID: PT01206, Histamine H1 receptor
Protein ID: PT01194, Histamine H3 receptor
Protein ID: PT01711, Histamine H4 receptor
Cell-based Assay
Protein ID: PT02997, Isocitrate dehydrogenase [NADP] cytoplasmic
Protein ID: PT01310, Muscarinic acetylcholine receptor M1
Protein ID: PT01198, Muscarinic acetylcholine receptor M2
Protein ID: PT01266, Muscarinic acetylcholine receptor M3
Protein ID: PT01156, Muscarinic acetylcholine receptor M4
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Cell-based Assay
Clinical Information about the Compound